ANI Pharmaceuticals ANIP Convertible Preferred Stock Authorized Shares
Convertible Preferred Stock Authorized Shares at other companies
Other financials
Where this comes from
Reported directly by ANI Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about ANI Pharmaceuticals's convertible preferred stock authorized shares.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ANI Pharmaceuticals's convertible preferred stock authorized shares?
- ANI Pharmaceuticals (ANIP) reported convertible preferred stock authorized shares of 1.7M in Q1 2026.
- How has ANI Pharmaceuticals's convertible preferred stock authorized shares changed year-over-year?
- ANI Pharmaceuticals's convertible preferred stock authorized shares decreased by 0.0% year-over-year, from 1.7M to 1.7M.
- What is the long-term trend for ANI Pharmaceuticals's convertible preferred stock authorized shares?
- Over 3 years (2022 to 2025), ANI Pharmaceuticals's convertible preferred stock authorized shares has grown at a 0.0% compound annual growth rate (CAGR), from 1.7M to 1.7M.
- What does convertible preferred stock authorized shares mean?
- Maximum number of convertible preferred shares the company is authorized to issue under its corporate charter.